Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture
Measurement of how much blood the heart pumps may be useful in guiding how much intravenous fluid to give patients during surgery. The current monitors either require special drips (arterial and/or central lines) or a probe inserted into the oesophagus (food pipe) which may limit their use. Newer monitors are available which are completely non-invasive and seem to work well in younger patients. Patients with hip fracture are elderly and frail. The investigators wish to see whether the newer non-invasive monitor works well enough compared to the current monitors in this group of patients. If it does this may allow more of these patients to be monitored in this way.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Validation of the Nexfin Non-invasive Cardiac Output Monitor in Patients Undergoing Hip Fracture Repair|
- Bias and limits of agreement of Nexfin recorded cardiac output compared with LiDCOplus [ Time Frame: During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia ] [ Designated as safety issue: No ]Analysis of agreement between Nexfin cardiac output and the calibrated cardiac output measured by LiDCOplus
- Bias and limits of agreement for change in cardiac output measured by Nexfin compared with LiDCO [ Time Frame: During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia ] [ Designated as safety issue: No ]Comparison of relative changes in cardiac output recorded by Nexfin and LiDCO in response to intra-anaesthesia / intra-operative events (fluid administration, drug administration)
- Utility of Nexfin monitor [ Time Frame: Intra-operative - average duration about 1 hour ] [ Designated as safety issue: No ]Proportion of time during anaesthesia and surgery when a valid signal is obtained from the Nexfin device.
- Adverse events associated with Nexfin monitor [ Time Frame: Intra-operative - average duration about one hour ] [ Designated as safety issue: Yes ]Recording of adverse events associated with use of the Nexfin monitor
|Study Start Date:||January 2013|
|Study Completion Date:||October 2013|
|Primary Completion Date:||October 2013 (Final data collection date for primary outcome measure)|
The investigators wish to compare the accuracy of the newer, non-invasive monitor (Nexfin) against a more established minimally invasive monitor (LiDCO). The LiDCO has a calibration system which allows the absolute accuracy of the Nexfin to be established.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01474824
|Nottingham University Hospitals|
|Nottingham, Notts, United Kingdom, NG7 2UH|
|Brighton and Sussex University Hospitals|
|Brighton, Sussex, United Kingdom, BN2 5BE|
|Principal Investigator:||Iain K Moppett, DM FRCA MRCP||University of Nottingham|